METHODS FOR THE TREATMENT OF TNF-alpha RELATED DISEASES
VE6142020000049SUndetermined Publication Date: 2022-02-17CELLTRION INC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- VE · VE
- Patent Type
- Designs
- Current Assignee / Owner
- CELLTRION INC
- Filing Date
- 2020-02-27
- Publication Date
- 2022-02-17
Need to check novelty before this filing date? Find Prior Art
Description
The present invention relates to methods for treating a TNF-alpha-related disease by subcutaneous administration of a TNF-alpha-binding antibody (anti-TNF-alpha antibody) or an antigen-binding fragment thereof. Compared to intravenous injection, the treatment method, composition, kit, or use according to the present invention offers the advantage of improved patient satisfaction by enhancing comfort and quality of life, i.e., by reducing the time required for administration and decreasing the patient's hospital stay.